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S U M M A R Y
We report an unusual case of Candida glabrata meningitis and endocarditis in a young Caucasian woman
with a prosthetic aortic valve and suffering from a dissecting thoraco-abdominal aortic aneurysm. C.
glabrata was isolated from culture of the cerebrospinal ﬂuid. Candida infection of the central nervous
system is an uncommon manifestation of disseminated infection due to Candida species. Our case report
also highlights the intrinsic resistance of C. glabrata to azoles.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Candida glabrata, formerly known as Torulopsis glabrata, is a
monomorphic yeast that commonly colonizes the gastrointestinal
and genitourinary tracts. For many years C. glabrata was
considered a relatively non-pathogenic saprophyte of the normal
ﬂora of healthy individuals and was not readily associated with
serious infection in humans. However, following the widespread
and ever-increasing use of immunosuppressive therapies together
with broad-spectrum antibiotic treatment, the frequency of
mucosal and systemic infections caused by C. glabrata has
increased signiﬁcantly in hospitalized patients worldwide. C.
glabrata currently represents the second most common cause of
fungal infections of the bloodstream, oropharynx, and urinary tract
after Candida albicans.1
Risk factors include antibacterial agents, steroids, malnutrition,
diabetes mellitus, intravenous catheters, and immunosuppression.
Differently from C. albicans, C. glabrata appears to have evolved a
stealth strategy based on evasion of the immune response and
persistence without causing severe damage. Accidental or
iatrogenic breaches of natural barriers via trauma, catheters,
surgery, or parenteral nutrition appear to be the preferred routes* Corresponding author. Tel.: +39 091 6554054; fax: +39 091 6554050.
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).by which C. glabrata reaches the bloodstream and invades tissues.2
Upon expression of adhesins, C. glabrata is able to attach and
colonize host tissues as well as abiotic surfaces, where it develops
as multilayered bioﬁlm structures. Bioﬁlm development contrib-
utes to increased resistance to antifungal agents and results in
persistent infection. Persistent infections are facilitated by the
ability of C. glabrata to survive and replicate inside the phagosome
of phagocytes, similar to Mycobacterium spp.3
2. Case report
We report the case of a 42-year-old woman admitted to the
Institute of Infectious Diseases, ‘‘Paolo Giaccone’’ University
Polyclinic in Palermo because of continuous-remittent fever
(maximum body temperature 38.5 8C), headache for 15 days,
and confusion, disorientation, diplopia, and vomiting for a few
hours.
She had a history of an extended, large (67 mm  25 mm), and
dissecting aneurysm (Stanford type A) of the thoraco-abdominal
aorta (involving the ascending portion up to the initial section of
the left iliac) and had undergone replacement of the ascending
aorta and aortic valve 4 months earlier. At that time a febrile
increase in temperature on the 10th postoperative day led to
treatment with broad-spectrum antimicrobials and her condition
improved. Two sets of blood cultures were drawn and yielded
C. glabrata. Oral ﬂuconazole was administered, as suggested by inciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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after 10 days.
At the current admission, the patient was febrile (body
temperature 37.7 8C), with an oxygen saturation of 96% by
pulse oximetry while breathing room air, blood pressure of 100/
60 mmHg, and a heart rate of 73 bpm. On physical examination,
she showed signs of meningeal irritation, mild confusion, and
diplopia. On cardiac auscultation a 3/6 systolic murmur all over the
precordium and a metallic click sound created by the mechanical
aortic valve prosthesis were heard.
Laboratory signs underlined a neutrophilic leukocytosis (white
blood cell count (WBC) 26.75  109/l with 89.2% neutrophils), mild
anaemia (haemoglobin 11.1 g/dl), and progressive renal failure
(uremia 158 mg/dl, creatinine 2.3 mg/dl, and glomerular ﬁltration
rate (GFR) 25 ml/min/1.73 m2). Lactate dehydrogenase was
1016 IU/l, D-dimer 3445 ng/ml, C-reactive protein 15.49 mg/dl,
international normalized ratio (INR) 1.52, and activated partial
thromboplastin time 25.0 s. Other laboratory parameters were
within the normal range.
An electrocardiogram showed tachycardia, left bundle branch
block, and a ﬁrst-degree atrioventricular block. A brain computed
tomography (CT) scan was performed and was negative. A chest CT
scan revealed right basal thickening. An abdominal CT scan
showed a thoracic and abdominal aortic aneurysm (5.6 cm in size).
Transoesophageal echocardiography (TEE) showed a vegetation of
the prosthetic aortic valve, characterized by a thickening and
irregularity of the contour of the sewing ring. TEE also showed a
dissecting thoraco-abdominal aneurysm. Three sets of blood
cultures were collected on the day of admission and empirical
antimicrobial therapy was started immediately with intravenous
(IV) daptomycin 500 mg daily, IV rifampin 300 mg every 12 h, and
IV gentamicin 80 mg every 8 h for a prosthetic valve infection. The
initial empirical therapy was given for a total treatment duration of
10 days.
Seven days after the beginning of treatment, the persistence of
fever, preceded by chills and headache, prompted a lumbar
puncture; the physicochemical results revealed turbid cerebrospi-
nal ﬂuid (CSF) containing WBC 3.0  106/l with 60% neutrophils
and 40% lymphocytes, glucose 40 mg/dl (serum glucose 130 mg/
dl), and protein 90 mg/dl. Yeasts were not observed on direct
microscopy of the CSF. Blood cultures, urine cultures, and culture of
the catheter tip were all negative. Multiple blood cultures were
negative for bacteria and fungi.
C. glabrata was isolated from the CSF culture. To assess the
sensitivity to antifungals, a broth colorimetric microdilution method
was used (Fungifast AFG) that allows susceptibility testing to ﬁve
antifungals. The minimum inhibitory concentrations for amphoter-
icin, ﬂuconazole, itraconazole, and voriconazole were 0.5, 8, 0.125,
and 1 mg/ml, respectively. IV therapy was started with liposomal
amphotericin B (3 mg/kg/daily) for 4 weeks and then oral
ﬂuconazole 400 mg daily was administered. The patient responded
well to therapy and her temperature normalized on the third day of
liposomal amphotericin B. A re-culture of the sample was carried
out, conﬁrming the isolation of C. glabrata. The rapid defervescence
of the patient after initiation of antifungal therapy attested to the
possible role of C. glabrata in the pathogenesis. The patient was
discharged and treatment was continued with oral ﬂuconazole.
A lumbar puncture after treatment was not performed due to
the improved clinical condition of the patient. Thirteen monthsafter admission a transthoracic echocardiogram showed no
residual vegetation, while the patient was in good condition.
The diplopia had also resolved. Lifelong therapy with oral
ﬂuconazole is expected to be necessary.
3. Discussion
Candida infection of the central nervous system (CNS) is an
uncommon manifestation of disseminated infection due to
Candida species. It may arise in the context of systemic candidiasis,
as a complication of a neurosurgical procedure (especially after CSF
shunt placement), or as an isolated chronic infection. Clinico-
pathological forms of Candida infection of the CNS include
meningitis and diffuse cerebritis with microabscesses, parenchy-
mal abscesses, and vasculitis. Meningitis is the most common
presentation. Most cases are due to C. albicans, with few reports of
C. glabrata and other species causing infection.4
Risk factors for the development of CNS candidiasis are
immunosuppression, previous treatment with antibiotics or
corticosteroids, preterm birth, recent abdominal surgery, neuro-
surgery and insertion of CSF derivative systems, intravenous drug
use, and intravascular catheters. Candida meningitis is due to
haematogenous spread from a distant focus, as has been described
in previous studies. In our case the starting focus of infection was
presumed to be the vegetative endocarditis on the prosthetic valve.
Both the endocarditis and meningitis can be considered late
consequences of the candidemia revealed during the previous
admission. Insufﬁcient treatment with antifungals may have
allowed the yeast to structure a bioﬁlm over the prosthetic
surface. From a clinical perspective, the most important feature of
Candida bioﬁlms is their role in increasing tolerance to conven-
tional antifungal therapy. Bioﬁlms of non-albicans Candida species
have also been shown to exhibit reduced antifungal susceptibility.5
C. glabrata may be intermediately resistant to all azoles, and
about 20% of strains develop resistance during therapy and
prophylaxis with ﬂuconazole. Fortunately, in our case the strain
isolated from the CSF culture was fully susceptible in vitro.
Intravenous amphotericin B was used successfully as ﬁrst-line
treatment, as recommended by the Infectious Diseases Society of
America 2009 guidelines for the treatment of systemic candidiasis.
Regular follow-up and chronic fungal suppression with oral
ﬂuconazole are expected to be necessary lifelong to prevent
relapses of the infection.
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